UniPR1331, with the CAS number 1809170-59-9, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific details about its structure and properties may vary, compounds like UniPR1331 are typically characterized by their unique molecular frameworks, which can influence their biological activity and interaction with target proteins. Such substances are often evaluated for their solubility, stability, and reactivity under various conditions. Additionally, they may exhibit specific pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), which are crucial for assessing their viability as drug candidates. The compound's efficacy and safety profile would also be determined through preclinical and clinical studies, focusing on its mechanism of action and potential side effects. Overall, UniPR1331 represents a class of compounds that are actively researched for their contributions to drug discovery and development.

UniPR1331 is a novel selective antagonist of the Eph-ephrin system.

UniPR1331

1809170-59-9: UniPR1331, with the CAS number 1809170-59-9, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific details about its structure and properties may vary, compounds like UniPR1331 are typically characterized by their unique molecular frameworks, which can influence their biological activity and interaction with target proteins. Such substances are often evaluated for their solubility, stability, and reactivity under various conditions. Additionally, they may exhibit specific pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), which are crucial for assessing their viability as drug candidates. The compound's efficacy and safety profile would also be determined through preclinical and clinical studies, focusing on its mechanism of action and potential side effects. Overall, UniPR1331 represents a class of compounds that are actively researched for their contributions to drug discovery and development.

((R)-4-((3S,8S,9S,10R,13R,14S,17R)-3-Hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)-L-tryptophan

<p>UniPR1331 is a novel selective antagonist of the Eph-ephrin system.</p>

CAS 1809170-59-9

UniPR1331

((R)-4-((3S,8S,9S,10R,13R,14S,17R)-3-Hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)-L-tryptophan

Ref: 54-OR1068598

UniPR1331

Ref: TM-T70159